Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 28Gastrointestinal 21Thoracic 15Gynecologic 15Genitourinary 11Other hematologic neoplasm 10Tumor-Agnostic 9Lymphoid 9Other solid neoplasm 7Other 7Dermatologic 5Sarcoma 4Head & Neck 4Plasma cell 2Other neoplasm 2CNS 2Myeloid 1Endocrine 1

Conditions

Multiple Myeloma 2Lymphoma 1

Interventions

Dexamethasone 393Bortezomib 246Lenalidomide 222Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 58Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Methods × Plasma cell × Clear all
NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT02129569 2017-03-20

Psychoeducational and Behavioral Strategies in Reducing Distress and Anxiety in Patients With Multiple Myeloma and Their Family Caregivers

Case Comprehensive Cancer Center

Phase NA Completed
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡